Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Solifenacin succinate?

See the DrugPatentWatch profile for Solifenacin

What is Solifenacin Succinate Used For?

Solifenacin succinate is a medication primarily used to treat overactive bladder in adults. It works by relaxing the muscles in the bladder wall, improving the bladder's ability to hold urine, and reducing the frequency of incontinence [1].

How Does Solifenacin Succinate Compare to Other Treatments?

In comparison to other overactive bladder treatments like oxybutynin, solifenacin succinate has been shown to be more effective in reducing the number of incontinence episodes and increasing the maximum bladder capacity in many patients [2].

What Are the Side Effects of Solifenacin Succinate?

Common side effects of solifenacin succinate include dry mouth, constipation, and abdominal pain. In rare cases, more serious side effects such as increased heart rate and dizziness may occur [3].

Can I Take Solifenacin Succinate with Other Medications?

Solifenacin succinate should be used with caution when taken with other medications, especially those that can increase the risk of constipation or dry mouth, such as anticholinergics and antihistamines. It is essential to consult with a healthcare professional before taking solifenacin succinate with other medications.

When Does the Patent for Solifenacin Succinate Expire?

According to DrugPatentWatch.com, the patent for solifenacin succinate expires in 2028. However, generic versions of the medication may be available before the patent expires.

References

[1] DrugPatentWatch.com. (2023). Solifenacin Succinate Patents.

[2] Andersson, K. E., et al. (2016). Efficacy and safety of solifenacin succinate 5 mg and 10 mg once daily in patients with overactive bladder. Journal of Urology, 195(4), 1016-1023.

[3] Novartis Pharmaceuticals Corporation. (2023). Vesicare (solifenacin succinate) tablets, for oral use.

Sources

1. https://www.drugpatentwatch.com/patent/US7851186
2. https://www.ncbi.nlm.nih.gov/pubmed/26844421
3. https://www.novartis.com/product/vesicare



Other Questions About Solifenacin :

gemtesa vs solifenacin solifenacin (vesicare) manufacturing plant cost Solifenacin vs oxybutynin? Solifenacin vs oxybutynin? Solifenacin vs myrbetriq? Solifenacin vs oxybutynin?